Bruce Julian is a Nephrology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 336 publications with 27,795 citations (h-index 85). By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1717 6th Ave S
Birmingham, AL 352331801
Telephone
800-822-8816Registry record last updated 25 Oct 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20251 payment
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20241 payment
- Travere Therapeutics, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
44.9%Angiotensin receptor blocker (ARB)31.5%Losartan Potassium100%Part D≥15 patientsBeta blocker13.5%Carvedilol100%Part D<11 patientsMetabolism & gastrointestinal
24.7%Corticosteroid24.7%Prednisone100%Part D<11 patientsAnti-infectives
18%Short-acting sulfonamides18%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1990–2023 per NIH RePORTER. The latest:
- Utilizing IgG Autoantibodies As Biomarkers In IgA Nephropathy
Reliant Glycosciences Llc
FY2023$616,309R44DK126526 - Utilizing IgG Autoantibodies As Biomarkers In IgA Nephropathy
Reliant Glycosciences Llc
FY2022$667,669R44DK126526 - APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center
University of Alabama at Birmingham
FY2020$133,332U01DK115997
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Bruce Korf, MD
University of Alabama at Birmingham
Michael Mugavero, MD
University of Alabama at Birmingham
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”